Unternehmen Mind Medicine (MindMed) Inc. Other OTC
Aktien
A2P09G
CA60255C1095
MMEDF
Biotechnologie
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | - | 14.01.21 |
Schond Greenway
DFI | Director of Finance/CFO | 52 | 23.05.22 |
Miri Wernli
PSD | President | 71 | 28.02.20 |
Daniel Karlin
CTO | Chief Tech/Sci/R&D Officer | 44 | 01.02.21 |
Madeline Feldman
ADM | Chief Administrative Officer | - | - |
Bridget Walton
PRN | Corporate Officer/Principal | - | 01.01.22 |
Robert Silva
PRN | Corporate Officer/Principal | - | 01.05.22 |
Corporate Officer/Principal | - | 05.04.22 | |
Carrie Liao
AUD | Comptroller/Controller/Auditor | 58 | 01.11.21 |
Peter Mack
PRN | Corporate Officer/Principal | - | 13.05.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 66 | 29.09.21 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 11.08.22 |
David Gryska
BRD | Director/Board Member | 68 | 21.06.23 |
Carol Vallone
CHM | Chairman | 67 | 29.09.21 |
Roger Crystal
BRD | Director/Board Member | 47 | 11.08.22 |
Miri Wernli
PSD | President | 71 | 28.02.20 |
Robert Barrow
CEO | Chief Executive Officer | - | 14.01.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 70 267 970 | 68 571 348 ( 97,59 %) | 0 | 97,59 % |
Unternehmenskontakt
Mind Medicine (MindMed), Inc.
One World Trade Center Suite 8500
10007, New York
+212-220-6633
http://www.mindmed.coSektor
% 1. Jan. | Kap. | |
---|---|---|
-0.02% | 42.11 Mrd. | |
+46.17% | 40.08 Mrd. | |
+5.04% | 40 Mrd. | |
-11.32% | 26.87 Mrd. | |
+5.25% | 24.58 Mrd. | |
-23.83% | 18.44 Mrd. | |
-1.62% | 11.94 Mrd. | |
+22.75% | 11.66 Mrd. | |
+6.44% | 11.01 Mrd. |